Nephrotic syndrome complicated with intracranial venous thrombosis treated with urokinase report of 5 cases

Nephrotic syndrome complicated with intracranial venous thrombosis treated with urokinase : report of 5 cases

OBJECTIVE: To explore the effect of urokinase and low molecular weight heparin in children with nephrotic syndrome complicated with intracranial venous thrombosis

Détails bibliographiques
Publié dans:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 48(2010), 5 vom: 26. Mai, Seite 338-41
Auteur principal: Xia, Zheng-kun (Auteur)
Autres auteurs: He, Xu, Fan, Zhong-min, Liu, Guang-ling, Gao, Yuan-fu, Fu, Jie, Ren, Xian-guo, Mao, Song, Huang, Qian
Format: Article
Langue:Chinese
Publié: 2010
Accès à la collection:Zhonghua er ke za zhi = Chinese journal of pediatrics
Sujets:Case Reports English Abstract Journal Article Research Support, Non-U.S. Gov't Fibrinolytic Agents Urokinase-Type Plasminogen Activator EC 3.4.21.73
LEADER 01000caa a22002652 4500
001 NLM19978907X
003 DE-627
005 20250211192141.0
007 tu
008 231223s2010 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0666.xml 
035 |a (DE-627)NLM19978907X 
035 |a (NLM)20654032 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Xia, Zheng-kun  |e verfasserin  |4 aut 
245 1 0 |a Nephrotic syndrome complicated with intracranial venous thrombosis treated with urokinase  |b report of 5 cases 
264 1 |c 2010 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 03.02.2011 
500 |a Date Revised 07.06.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To explore the effect of urokinase and low molecular weight heparin in children with nephrotic syndrome complicated with intracranial venous thrombosis 
520 |a METHODS: Urokinase and low molecular weight heparin were administered to the 5 patients intravenously. The initial dose of urokinase was 2000 - 4000 U/(kg.d), the initial pulse dose was 20 000 - 40 000 U given within 15 - 30 minutes, and the left was infused by using a pump, from the second day 2000 U/(kg.d) urokinase was infused daily for 3 to 7 days. During the treatment thrombin time (TT), activated partial thromboplastin time (APTT) were tested 3 times every week, with particular attention to bleeding. Low molecular weight heparin 100 - 120 AXaIU/kg, 1 or 2 times per day was hypodermally injected for a course of two weeks. Anti-platelet drugs: long-term oral administration of dipyridamole 3 - 5 mg/(kg.d) was applied 2 - 3 times every day for 3 months 
520 |a RESULTS: The clinical symptoms disappeared after one month of the combined therapy of urokinase, low molecular weight heparin and dipyridamole in 5 cases of nephrotic syndrome complicated with intracranial venous thrombosis in children, the plasma viscosity returned to normal in 1 month, activated partial thromboplastin time, prothrombin time, fibrinogen degradation products returned to normal in 1 to 2 months, venous thrombosis disappeared after 1 to 3 months in head CT or MRI examination, showing the cerebral venous sinus thrombosis complete recanalization without relapse cases in follow-up 
520 |a CONCLUSION: The early application of urokinase and low molecular heparin and anti-platelet coagulation drugs was effective. The early diagnosis, treatment and prevention of intracranial vein thrombosis in patients with nephrotic syndrome is important 
650 4 |a Case Reports 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Fibrinolytic Agents  |2 NLM 
650 7 |a Urokinase-Type Plasminogen Activator  |2 NLM 
650 7 |a EC 3.4.21.73  |2 NLM 
700 1 |a He, Xu  |e verfasserin  |4 aut 
700 1 |a Fan, Zhong-min  |e verfasserin  |4 aut 
700 1 |a Liu, Guang-ling  |e verfasserin  |4 aut 
700 1 |a Gao, Yuan-fu  |e verfasserin  |4 aut 
700 1 |a Fu, Jie  |e verfasserin  |4 aut 
700 1 |a Ren, Xian-guo  |e verfasserin  |4 aut 
700 1 |a Mao, Song  |e verfasserin  |4 aut 
700 1 |a Huang, Qian  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 48(2010), 5 vom: 26. Mai, Seite 338-41  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:48  |g year:2010  |g number:5  |g day:26  |g month:05  |g pages:338-41 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 48  |j 2010  |e 5  |b 26  |c 05  |h 338-41